The alternative (“alt-“) animal products industry is growing increasingly more popular each year, causing an increased demand in foods made from plant proteins or cultured in a lab. As more alt-animal products emerge, the amount of foodtech patents increases and the foodtech patent landscape becomes more and more complex. In this article, we will provide
Federal funding is a huge boon for companies, universities, and research institutions conducting innovative research. However, it comes attached with requirements that can become a stumbling block, especially for emerging and smaller companies. Any invention conceived or reduced to practice with the assistance of federal funding is subject to the Bayh-Dole Act, which provides
Gene therapies have been the subject of tremendous scientific research and investment. With hundreds of clinical trials in progress and many target applications, the biotechnology, agricultural, and pharmaceutical fields are pushing full speed ahead into this promising field. Helping spur innovations in this field are important issues to be addressed including preventing off-target effects, engineering
In a cautionary tale for inventors participating in trade shows and other non-confidential presentations, on February 15, 2023, the U.S. Court of Appeals for the Federal Circuit affirmed a district court decision invalidating a patent claim where, more than one year before filing a patent application, the patent owner demonstrated a working prototype of the
Substantial patent litigation activity occurred in the mRNA space in 2022, involving nearly all of the major mRNA and lipid nanoparticle (LNP) pioneers. Since this is the most significant happening in this space with respect to IP in 2022, this post will provide an overview of that activity as well as a summary exposure analysis.
